Loading organizations...
The Technion Investment Opportunities Fund (TIOF) is an investment vehicle commercializing innovations from the Technion – Israel Institute of Technology. It provides Series A and B funding, often co-investing in its portfolio. TIOF strategically backs ventures in consumer nondurables, LOHAS and wellness, TMT, and food technology, leveraging Technion’s intellectual property for development.
TIOF was founded by the Technion and its R&D Foundation (TRDF). This partnership aims to preserve the institution’s equity stake in its spin-off companies. Its creation offers a direct path to translate academic research into viable commercial entities, securing Technion's continued involvement and benefit.
TIOF invests in companies utilizing intellectual property and research from Technion faculty and graduates. Its vision cultivates an ecosystem where university advancements achieve significant real-world impact. The fund aims to generate lasting value by supporting the commercial growth of these innovative ventures.
Technion Innovation Opportunities Fund has 2 tracked investments across 2 companies. The latest tracked deal is $12.0M Series A in Aleph Farms in May 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 14, 2019 | Aleph Farms | $12.0M Series A | Kenneth LEE | JON Nash, CPT Capital, Jesselson, M Industry, NEW Crop Capital, Peregrine Ventures, Strauss Group, U.s. Venture |
| Feb 11, 2016 | Regentis Biomaterials | $15.0M Series D | Haisco Pharmaceutical Group | Generali, Medica Venture Partners, SCP Vitalife Partners, Technion Research And Development Foundation |
